Pathogenic mechanisms underlying idiopathic pulmonary fibrosis

BJ Moss, SW Ryter, IO Rosas - Annual Review of Pathology …, 2022‏ - annualreviews.org
The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell
types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in …

[HTML][HTML] Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches

IA Savin, MA Zenkova, AV Sen'kova - International journal of molecular …, 2022‏ - mdpi.com
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Map** spatially resolved transcriptomes in human and mouse pulmonary fibrosis

L Franzén, M Olsson Lindvall, M Hühn, V Ptasinski… - Nature Genetics, 2024‏ - nature.com
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and
limited treatment options. Efforts to identify effective treatments are thwarted by limited …

Immune mechanisms of pulmonary fibrosis with bleomycin

Y Ishida, Y Kuninaka, N Mukaida, T Kondo - International journal of …, 2023‏ - mdpi.com
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function,
often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and …

An official American Thoracic Society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis

RG Jenkins, BB Moore, RC Chambers… - American journal of …, 2017‏ - atsjournals.org
Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis
using animal models, yet few of these compounds have replicated these beneficial effects in …

Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis

N **e, Z Tan, S Banerjee, H Cui, J Ge… - American journal of …, 2015‏ - atsjournals.org
Rationale: Dysregulation of cellular metabolism has been shown to participate in several
pathologic processes. However, the role of metabolic reprogramming is not well appreciated …

The bleomycin model of pulmonary fibrosis

T Liu, FG De Los Santos, SH Phan - Fibrosis: Methods and Protocols, 2017‏ - Springer
Interstitial lung disease (ILD) comprises a large number of chronic lung disease
characterized by varying degrees of inflammation and fibrosis. Mostly they are idiopathic …

Exploring animal models that resemble idiopathic pulmonary fibrosis

J Tashiro, GA Rubio, AH Limper, K Williams… - Frontiers in …, 2017‏ - frontiersin.org
Large multicenter clinical trials have led to two recently approved drugs for patients with
idiopathic pulmonary fibrosis (IPF); yet, both of these therapies only slow disease …

The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

RC Russo, CC Garcia, MM Teixeira… - Expert review of clinical …, 2014‏ - Taylor & Francis
Chemokines are small proteins that control several tissue functions, including cell
recruitment and activation under homeostatic and inflammatory conditions. CXCL8 …

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis

VJ Craig, L Zhang, JS Hagood… - American journal of …, 2015‏ - atsjournals.org
Idiopathic pulmonary fibrosis (IPF) is a restrictive lung disease that is associated with high
morbidity and mortality. Current medical therapies are not fully effective at limiting mortality …